Nature launches Nature Progress Brain Health — new selective open-access journal for neurotech and brain health research
Summary
Nature announced the launch of Nature Progress Brain Health — a selective open-access journal within the Nature Portfolio dedicated to research on brain health, neurotechnology, and neurological disease — as noted in Neurotech Notables #51. The journal sits alongside Nature Medicine, Nature Neuroscience, and Nature Biomedical Engineering in the Nature publishing family, providing a dedicated peer-reviewed venue for translational brain health research including BCI clinical trials, neuromodulation outcomes, EEG biomarkers, and digital health neurotechnology. The launch reflects Nature Portfolio's recognition that brain health is a field of sufficient scientific significance to merit a dedicated journal within the world's most prestigious scientific publishing brand.
Why it matters
A Nature-branded journal specifically for brain health research provides the BCI and neuromodulation field with a peer-review venue at the highest credibility tier of scientific publishing. Historically, BCI and neuromodulation papers have competed for space in Nature Medicine, Nature Biomedical Engineering, NEJM, and JAMA — journals with much broader scope. A dedicated Nature brain health journal creates a natural home for translational neurotech research and signals Nature Portfolio's institutional commitment to the field.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial